Title | Type | SJR | H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Journal of Nanobiotechnology | journal | 1.770 Q1 | 109 | 34 | 35 | 1349 | 250 | 33 | 5.25 | 39.68 | |
52 | Nanomedicine: Nanotechnology, Biology, and Medicine | journal | 1.768 Q1 | 151 | 92 | 138 | 3602 | 929 | 134 | 5.68 | 39.15 | |
53 | Current Medicinal Chemistry | journal | 1.700 Q1 | 202 | 289 | 800 | 38208 | 4319 | 799 | 5.25 | 132.21 | |
54 | CNS Drug Reviews | journal | 1.699 Q1 | 64 | 0 | 26 | 0 | 154 | 26 | 0.00 | 0.00 | |
55 | European Neuropsychopharmacology | journal | 1.692 Q1 | 130 | 95 | 332 | 5527 | 1462 | 326 | 4.43 | 58.18 | |
56 | Cardiovascular Drug Reviews | journal | 1.673 Q1 | 54 | 0 | 25 | 0 | 134 | 24 | 0.00 | 0.00 | |
57 | Current Gene Therapy | journal | 1.672 Q1 | 80 | 47 | 127 | 4735 | 653 | 123 | 4.98 | 100.74 | |
58 | BioDrugs | journal | 1.664 Q1 | 79 | 47 | 119 | 2941 | 576 | 111 | 5.36 | 62.57 | |
59 | Current Opinion in Drug Discovery and Development | journal | 1.661 Q1 | 85 | 68 | 221 | 4845 | 1124 | 204 | 5.31 | 71.25 | |
60 | Pharmacogenomics Journal | journal | 1.661 Q1 | 95 | 51 | 136 | 2259 | 714 | 133 | 4.63 | 44.29 | |
61 | Current Pharmaceutical Design | journal | 1.657 Q1 | 183 | 409 | 1056 | 45111 | 4994 | 943 | 4.85 | 110.30 | |
62 | Drug Safety | journal | 1.620 Q1 | 140 | 103 | 311 | 4330 | 1295 | 259 | 4.04 | 42.04 | |
63 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
64 | Toxicology and Applied Pharmacology | journal | 1.577 Q1 | 189 | 286 | 980 | 15088 | 4453 | 957 | 4.35 | 52.76 | |
65 | International Journal of Pharmaceutics | journal | 1.574 Q1 | 258 | 641 | 1709 | 22382 | 7443 | 1692 | 4.15 | 34.92 | |
66 | Alcoholism: Clinical and Experimental Research | journal | 1.568 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
67 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.552 Q1 | 82 | 11 | 38 | 1827 | 176 | 38 | 3.84 | 166.09 | |
68 | Critical Reviews in Toxicology | journal | 1.546 Q1 | 129 | 43 | 114 | 5878 | 625 | 106 | 4.84 | 136.70 | |
69 | Expert Opinion on Drug Delivery | journal | 1.546 Q1 | 133 | 97 | 253 | 9623 | 1281 | 242 | 5.11 | 99.21 | |
70 | Chemical Research in Toxicology | journal | 1.537 Q1 | 177 | 215 | 724 | 10210 | 3212 | 694 | 4.63 | 47.49 | |
71 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
72 | Tetrahedron | journal | 1.526 Q1 | 236 | 1187 | 3954 | 59908 | 12586 | 3926 | 3.08 | 50.47 | |
73 | Drug Metabolism and Disposition | journal | 1.508 Q1 | 194 | 289 | 920 | 9178 | 4048 | 918 | 4.20 | 31.76 | |
74 | Clinical Trials | journal | 1.507 Q1 | 74 | 76 | 188 | 1771 | 404 | 153 | 2.13 | 23.30 | |
75 | Journal of Clinical Pharmacology | journal | 1.502 Q1 | 130 | 165 | 443 | 3971 | 1749 | 422 | 3.99 | 24.07 | |
76 | Nanotoxicology | journal | 1.501 Q1 | 107 | 32 | 85 | 1602 | 429 | 82 | 3.54 | 50.06 | |
77 | AAPS Journal | journal | 1.494 Q1 | 132 | 82 | 189 | 3723 | 983 | 185 | 4.10 | 45.40 | |
78 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 | |
79 | Pharmacogenetics and Genomics | journal | 1.479 | 152 | 96 | 347 | 4069 | 1634 | 342 | 4.31 | 42.39 | |
80 | Pharmacological Research | journal | 1.479 Q1 | 169 | 133 | 372 | 8179 | 1762 | 359 | 4.09 | 61.50 | |
81 | International Journal of Nanomedicine | journal | 1.447 Q1 | 179 | 114 | 132 | 4325 | 719 | 129 | 5.99 | 37.94 | |
82 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.438 Q1 | 99 | 27 | 70 | 2257 | 349 | 66 | 4.91 | 83.59 | |
83 | Addictive Behaviors | journal | 1.429 Q1 | 149 | 200 | 663 | 7546 | 1905 | 662 | 2.43 | 37.73 | |
84 | Journal of Pharmaceutical Sciences | journal | 1.423 Q1 | 206 | 436 | 1074 | 17118 | 4031 | 1036 | 3.56 | 39.26 | |
85 | Antiviral Research | journal | 1.409 Q1 | 151 | 190 | 383 | 11217 | 1674 | 383 | 4.74 | 59.04 | |
86 | Current Topics in Medicinal Chemistry | journal | 1.399 Q1 | 133 | 138 | 497 | 13860 | 1873 | 424 | 3.66 | 100.43 | |
87 | Ecotoxicology | journal | 1.380 Q1 | 107 | 160 | 277 | 8344 | 894 | 275 | 3.20 | 52.15 | |
88 | Drug Metabolism Reviews | journal | 1.371 Q1 | 108 | 39 | 93 | 4582 | 469 | 88 | 4.58 | 117.49 | |
89 | Journal of Natural Products | journal | 1.370 Q1 | 161 | 392 | 1254 | 11108 | 4184 | 1232 | 3.10 | 28.34 | |
90 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
91 | Behavioural Pharmacology | journal | 1.359 Q1 | 87 | 81 | 250 | 5428 | 726 | 247 | 2.65 | 67.01 | |
92 | Current Drug Targets | journal | 1.356 Q1 | 119 | 159 | 397 | 17091 | 1370 | 355 | 3.09 | 107.49 | |
93 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.354 Q1 | 108 | 86 | 228 | 7351 | 984 | 208 | 4.00 | 85.48 | |
94 | Journal of Psychopharmacology | journal | 1.351 Q1 | 135 | 231 | 378 | 9785 | 1310 | 326 | 3.14 | 42.36 | |
95 | Human Genomics | journal | 1.348 Q1 | 68 | 36 | 53 | 834 | 122 | 43 | 2.30 | 23.17 | |
96 | Journal of NeuroImmune Pharmacology | journal | 1.344 Q1 | 91 | 55 | 126 | 4586 | 441 | 119 | 3.48 | 83.38 | |
97 | Current Opinion in Molecular Therapeutics | journal | 1.336 Q1 | 67 | 88 | 220 | 5913 | 801 | 203 | 3.88 | 67.19 | |
98 | Reproductive Toxicology | journal | 1.334 Q1 | 129 | 137 | 348 | 6145 | 1524 | 328 | 3.41 | 44.85 | |
99 | Pharmacology Biochemistry and Behavior | journal | 1.320 Q1 | 148 | 226 | 686 | 12373 | 2176 | 682 | 2.94 | 54.75 | |
100 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.317 Q1 | 150 | 300 | 909 | 11862 | 2754 | 724 | 2.92 | 39.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®